ArticleLeukemia2020

Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS.

Joshua F Zeidner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.